2738. Two-step sulfonamide antibiotic challenges in patients who require treatment with trimethoprim-sulfamethoxazole at an academic medical center: Outcomes in a largely immunocompromised population

BACKGROUND: Sulfonamide antibiotic allergy is the second most reported medication allergy. The allergy label limits the use of trimethoprim-sulfamethoxazole (TMP-SMX), the antibiotic of choice for pneumocystis jirovecii pneumonia (PJP), Toxoplasma, and many types of urinary tract infections. Immunoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Samhan, Aya, Joshi, Shyam, Ham, YoungYoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677036/
http://dx.doi.org/10.1093/ofid/ofad500.2349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677036/
http://dx.doi.org/10.1093/ofid/ofad500.2349

Ejemplares similares